Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X/Twitter:
1. ”BMI, weight change, and cancer prognosis: a meta-analysis of 73 cohort studies ESMO Open.
Obesity vs. normal weight
- worse OS: breast cancer, glioblastoma;
- better OS: GI, lung and renal cancers;
Underweight vs. normal weight
- worse OS: breast, GI, lung, head and neck cancers
Weight loss vs. nonweight change
- worse OS: GI cancers
Keeping normal body weight before and after diagnosis of the cancer may be the best.”
Read further.
Source: Erman Akkus/X
2. ”Biliary Tract Cancers: French National Clinical Practice Guideline.
- Localized disease: surgery and adjuvant capecitabine.
- No neoadjuvant treatment is validated to date.
- Advanced disease: Cisplatin-gemcitabine-durvalumab.
- Early biomarker testing.
- Second line: FOLFOX.”
Read further.
Source: Erman Akkus/X
